• Jobs
  • Startups
  • Hire
LoginSign up

Character Biosciences

Organization banner

Character Biosciences has 3 open roles, 2 posted in the last 30 days. Stated pay range: $115k – $270k a year. Funding stage: Series B. Last round: Sep 17, 2025.

Open roles

  • Character Biosciences logo
    Director / Senior Director, Quality

    Character Biosciences

    • Remote (United States)
    • Remote · Director / Executive
    • $200k–$270k
    Rippling
    Posted 29d ago
  • Character Biosciences logo
    Scientist / Senior Scientist Translational Biology

    Character Biosciences

    • Brisbane, CA
    • On-site · Senior
    • $115k–$170k
    Rippling
    Posted 29d ago
  • Character Biosciences logo
    Data Scientist I / II

    Character Biosciences

    • Jersey City, NJ
    • On-site · Mid-level
    • $132k–$175k
    AI-native
    Rippling
    Posted 178d ago

About

Character Biosciences logo

Character Biosciences

A patient-driven drug discovery platform for diseases of aging

Character Biosciences is a precision medicine company transforming drug development for progressive, polygenic diseases, beginning with ophthalmology. Our mission is to identify the genetic and molecular drivers of disease progression so we can develop targeted therapies for patients who urgently need them. We've built one of the most comprehensive resources in age-related eye diseases by partnering with over 150 ophthalmology clinics to integrate genetics with longitudinal clinical and imaging data. This deep phenotyping approach enables us to reclassify complex diseases like age-related macular degeneration (AMD) into genetically defined subtypes, unlocking novel therapeutic targets and optimizing patient selection for clinical trials. Character Bio’s AI-powered platform combines genomics, multi-modal data, and machine learning to discover and develop therapies that are more precise and more effective. Our lead programs, CTX114 and CTX203, are advancing toward clinical trials and

Private companySeries B
Founded2019
HQSan Francisco, United States
Unlock human wisdom
ThesisTermsPrivacy
Size
11–50 employees
IndustryBiotechnology
Funding
  • Series B · Sep 17, 2025

Claim characterbio.com

Work at characterbio.com? Sign in to claim this org and manage its profile.

© 2026 Saywise Inc.